FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a biologically compatible polysaccharide gel composition possessing the properties of prolonged release and containing triamcinolone acetonide engrafted to hyaluronic acid by covalent binding of triamcinolone acetonide and hyaluronic acid.
EFFECT: invention provides controlled release of the active ingredient representing triamcinolone acetonide.
19 cl
Authors
Dates
2013-01-20—Published
2008-11-26—Filed